Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Contract Research & Services
Contract Services
Return to: PBR Home | Contract Research & Services | Contract Services

Contract Services

Akebia expands anemia drug collaboration with Otsuka By PBR Staff Writer
US-based Akebia Therapeutics has expanded its collaboration with Japan's Otsuka Pharmaceutical on an anemia treatment.
Contract Research & Services > Contract Services > News
Immune Pharmaceuticals licenses cancer treatment's Latin America rights to Pint Immune Pharmaceuticals has entered into a letter of intent with Pint Pharma regarding license and commercializion of Ceplene in Latin America.
Contract Research & Services > Contract Services > News PureTech signs licensing and equity deal with Novartis to advance clinical stage mTORC1 programs PureTech Health has signed a licensing and equity agreement with Novartis to advance two clinical-stage programs targeting the mechanistic target of rapamycin complex 1 (mTORC1) pathway.
Contract Research & Services > Contract Services > News
See more Contract Services news

Latest Contract Services News and Insight

View all Contract Services news or find news targeted to your interests
21st Century Cures Act, Patient-Focused Drug Development: Just what the patient ordered
The 21st Century Cures Act, enacted into law December of 2016, is an initiative to expedite and enhance the process of discovery, development, and delivery for disease treatments.
Contract Research & Services > Contract Services > Press Releases
NSF: Education Is What Remains When Training Has Been Forgotten!
We all know pharmaceutical products are only as good as the people involved in making them. How a company educates its people is vital to the overall company success. Of major concern to the pharmaceutical industry is that many companies still resort to traditional (in some cases, tick-box) training methods – rather than educating staff at all levels for lasting improvement.
Contract Research & Services > Contract Services > Press Releases
NSF- A Final Word on KPIs – A Case Study From a Site Quality Head
Leadership had mixed views of KPIs. Many did not distinguish between leading and lagging, and none focused on behavior first, measure second. We set out to address these issues.
Contract Research & Services > Contract Services > Case Studies
NSF asks a Production Director for their views on moving forward with KPIs
| By NSF Health Sciences Pharma Biotech PBR
KPIs and the Production Director: Select Fewer, More Significant KPIs and Set Goals for Your Metrics
Contract Research & Services > Contract Services > White Papers
PureTech signs licensing and equity deal with Novartis to advance clinical stage mTORC1 programs
PureTech Health has signed a licensing and equity agreement with Novartis to advance two clinical-stage programs targeting the mechanistic target of rapamycin complex 1 (mTORC1) pathway.
Contract Research & Services > Contract Services > News
View all Contract Services news or find news targeted to your interests